Medicure Inc. (MPH) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Medicare's Earnings Conference Call for the quarter ended June 30th, 2026. My name is Holly and I will be your operator for today's call. At this time, all participants are in listen-only mode. Before we proceed, I would like to remind everyone that this presentation contains forward-looking statements relating to future results, events, and expectations, which are made pursuant to the Safe Harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties which could cause the company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, those described in the company's most recent annual information form and Form 20-F. Later, we will conduct a question and answer session. Please note that this conference call is being recorded and today's date is August 17th, 2026. I would now like to turn the conference call over to Dr. Albert Friesen, Chief Executive Officer of Medicare Inc. Please go ahead, Dr. Friesen. Thank you, Holly, and welcome to all on the call. We appreciate your interest and participation in today's call. Joining me today on the Q2 26 conference call is James Kinley, Medicare's Chief Financial Officer. Net revenue for the quarter was $7.4 million compared to $6.7 million for the quarter ending June 30th, 2025. The company recorded a net loss for the quarter ending in June 30th of $1.4 million or 14 cents per share. compared to a net loss of $786,000 for the quarter ending June 30th, 2025. And that loss is due largely in part to the $864,000 rebate liability recorded in the selling expense pertaining to the Centers for Medicare and Medicaid Services assessment. $608,000 invested als...